[Relationship between benign prostatic hyperplasia and prostate cancer: new opportunities for prostate cancer chemoprevention].

Abstract

In a review article the relationship between benign prostatic hyperplasia (BPH) and prostate cancer (PC) has been conducted. Epidemiological data on increasing the risk of PC in patients with BPH are presented. There are discussed common for BPH and PC constitutional, food, and life style etiologic factors and also common for the both diseases pathogenetic factors such as androgens, inflammation, metabolic syndrome. Pharmaceutical drugs and natural agents that have unidirectional therapeutic and preventive effect on BPH and PC are presented. Results of experimental studies of the authors to prove the link between BPH and PC are presented. It is concluded that BPH is a risk factor for PC and, ideally, drugs for the treatment of BPH should have a chemo preventive effect on PC.

• Authors: V G Bespalov, A A Kuzhanov, I N Vasilieva, A L Semenov, V A Alexandrov
• Journal: Voprosy onkologii (Vopr Onkol) 2016 Vol. 62 Issue 2 Pg. 360-71 ISSN: 0507-3758 [Print] Russia (Federation)
• PMID: 30462461 (Publication Type: Journal Article, Lecture)

Chemical References

• Antineoplastic Agents

Topics

• Antineoplastic Agents (therapeutic use)
• Humans
• Male
• Prostatic Hyperplasia (metabolism, pathology, prevention & control)
• Prostatic Neoplasms (metabolism, pathology, prevention & control)
• Risk Factors